Healthcare Industry Developments | BioTuesdays by Kilmer Lucas IR

Developments

TransMedics receives positive FDA advisory committee vote for OCS Heart System

The FDA’s Circulatory Systems Device Advisory Panel issued a favorable vote in support of approval of TransMedics Group’s (NASDAQ:TMDX) OCS Heart System to the FDA’s Office of Health Technology 2 (Cardiovascular...

April 7, 2021

Developments

IntelGenx ships first CBD filmstrip order to Heritage Cannabis

IntelGenx (TSXV:IGX; OTCQB:IGXT) completed its first shipment, consisting of 75,000 CBD filmstrips, to Heritage Cannabis Holdings (CSE:CANN) for the Canadian and Australian markets. The CBD filmstrips were produced at...

April 1, 2021

Developments

111, Inc., Jianming Pharma to develop chronic disease management platform in China

111, Inc. (NASDAQ:YI), a leading digital healthcare platform company in China, and Jianming Pharmaceutical Group signed a strategic cooperation agreement to develop an online chronic disease management platform for the...

March 25, 2021

Developments

Lineage presents additional interim data with OpRegen in dry AMD with GA

Lineage Cell Therapeutics (NYSE American, TASE:LCTX) presented new positive interim results from its ongoing, 24-patient Phase 1/2a clinical study of its lead product candidate, OpRegen, for the treatment of dry age...

March 23, 2021

Developments

Hepion Pharma reports new positive nonclinical antifibrotic data with CRV431

Hepion Pharmaceuticals (NASDAQ:HEPA) reported positive results from an in vivo study of CRV431 in a diet-induced animal model of non-alcoholic fatty liver disease (DIAMOND). Hepion’s CRV431 administered orally and once...

March 23, 2021

Developments

Diabeloop, BIOCORP in personalized diabetes management pact

Diabeloop and BIOCORP (FR0012788065 – ALCOR) are collaborating to offer new, simple and personalized treatment options to people living with diabetes. BIOCORP has developed and markets Mallya, an intelligent sensor for...

March 22, 2021

Developments

111 Inc. posts 96.1% jump in Q4 net revenue; beating guidance

Shanghai-based 111 Inc. (NASDAQ:YI) reported net revenue of $405.1-million (U.S.) in the fourth quarter of 2020, which was up 96.1%, from the year earlier quarter, beating its previous guidance of 81% to 90% growth. Net...

March 18, 2021

Developments

Hepion Pharma, ENDRA Life Sciences to collaborate in Hepion’s NASH trial

Hepion Pharmaceuticals (NASDAQ:HEPA) and ENDRA Life Sciences (NASDAQ:NDRA) signed a collaboration agreement to incorporate ENDRA’s Thermo Acoustic Enhanced UltraSound (TAEUS) as an add-on technology to support...

March 18, 2021

Developments

111, Inc. in strategic partnership with BeiGene

111, Inc. (NASDAQ:YI), a leading digital healthcare platform in China, entered into a strategic cooperation agreement with BeiGene (NASDAQ:BGNE; HKEX:06160), a commercial-stage and development biotechnology company...

March 17, 2021

Developments

111, Inc. achieves full distribution coverage across mainland China

111, Inc. (NASDAQ:YI) opened two new state-of-the-art, technology-driven fulfillment centers in the Northern cities of Xi’an and Shenyang, bringing the company’s total number of fulfillment centers to eight. The...

March 16, 2021

Developments

IntelGenx, atai Life Sciences in strategic pact; atai to purchase significant ownership stake

IntelGenx (TSXV:IGX; OTCQB:IGXT), a leader in pharmaceutical films, agreed to a strategic partnership with atai Life Sciences to develop treatments for mental health disorders. Under the accord, atai initially will...

March 15, 2021

Developments

Coridea, Deerfield to accelerate medtech innovation at NYC site

Coridea and Deerfield Management have established Deerfield Device Design and Development Catalyst to advance medtech innovation and accelerate the formation of commercial companies. Coridea is a medtech incubator;...

March 9, 2021

Developments

Azura Ophthalmics posts positive Phase 2 results in Meibomian gland dysfunction

Closely-held Azura Ophthalmics of Israel announced positive topline results from a Phase 2 program evaluating the company’s investigational therapy for the treatment of Meibomian gland dysfunction (MGD). The company’s...

March 5, 2021

Developments

BriaCell Therapeutics closes $25-million public offering

BriaCell Therapeutics (TSXV:BCT; NASDAQ:BCTX, BCTXW) closed a U.S. offering of 4,852,353 units at a price of $4.25 a unit and 1,030,000 pre-funded units at a price of $4.24 a unit for gross proceeds of about $25-million...

February 26, 2021

Developments

KA Imaging to present lateral dual-energy X-ray views at ECR 2021

Closely-held KA Imaging will present a poster on results from a study examining the feasibility of lateral chest dual-energy subtraction radiography using a stacked single-exposure multi-layer x-ray detector at the...

February 24, 2021

Developments

IntelGenx receives U.S. patent allowance for DisinteQ disintegrating THC oral film

The U.S. Patent and Trademark Office granted a notice of allowance for an IntelGenx (TSXV:IGX; OTCQB:IGXT) patent application entitled, “Film Dosage Form with Extended Release Mucoadhesive Particles.” This film...

February 17, 2021

Developments

HEXO to acquire Zenabis Global

HEXO (TSX, NYSE:HEXO) agreed to acquire Zenabis Global (TSX:ZENA) by way of a court-approved plan of arrangement under the Business Corporations Act of British Columbia, in an all-share transaction valued at...

February 16, 2021

Developments

Notch Therapeutics in $85-million financing for stem cell cancer immunotherapies

Closely-held Notch Therapeutics closed an $85-million series A financing to support continuing development of its portfolio of induced pluripotent stem cell (iPSC)-derived T-cell therapeutic product candidates and...

February 10, 2021

Developments

Richardson Wealth, Bloom Burton in healthcare alliance to expand wealth solutions

Richardson Wealth, a unit of RF Capital Group (TSX:RCG), and Bloom Burton, two Canadian financial services firms, entered into a strategic alliance dedicated exclusively on the healthcare sector. The strategic alliance...

February 9, 2021

Developments

MD Anderson completes second cohort dosing in Phase 1b trial of Soricimed’s SOR-C13

MD Anderson Cancer Center has completed patient dosing in the second cohort of a Phase 1b investigator-initiated trial of Soricimed Biopharma’s lead drug candidate, SOR-C13, for the targeted treatment of solid tumor...

February 8, 2021

Developments

IntelGenx files provisional U.S. patent for VetaFilm high loading oral film platform

IntelGenx (TSXV:IGX; OTCQB:IGXT) filed a new provisional patent application with the U.S. Patent and Trademark Office entitled, “High Loading Oral Film Formulation.” The patent application covers the incorporation of...

February 8, 2021

Developments

111 Inc. in pact with Jilin Baiyi Doctor Group for internet medical services

111 Inc. (NASDAQ:YI) and Jilin Baiyi Doctor Group Management entered into a strategic partnership to leverage the capabilities of 111’s digital platform to provide SMART-enabled healthcare services and doctor...

February 5, 2021

TransMedics receives positive FDA advisory committee vote for OCS Heart System

IntelGenx ships first CBD filmstrip order to Heritage Cannabis

111, Inc., Jianming Pharma to develop chronic disease management platform in China

Lineage presents additional interim data with OpRegen in dry AMD with GA

Hepion Pharma reports new positive nonclinical antifibrotic data with CRV431

Diabeloop, BIOCORP in personalized diabetes management pact

111 Inc. posts 96.1% jump in Q4 net revenue; beating guidance

Hepion Pharma, ENDRA Life Sciences to collaborate in Hepion’s NASH trial

111, Inc. in strategic partnership with BeiGene

111, Inc. achieves full distribution coverage across mainland China

IntelGenx, atai Life Sciences in strategic pact; atai to purchase significant ownership stake

Coridea, Deerfield to accelerate medtech innovation at NYC site

Azura Ophthalmics posts positive Phase 2 results in Meibomian gland dysfunction

BriaCell Therapeutics closes $25-million public offering

KA Imaging to present lateral dual-energy X-ray views at ECR 2021

IntelGenx receives U.S. patent allowance for DisinteQ disintegrating THC oral film

HEXO to acquire Zenabis Global

Notch Therapeutics in $85-million financing for stem cell cancer immunotherapies

Richardson Wealth, Bloom Burton in healthcare alliance to expand wealth solutions

MD Anderson completes second cohort dosing in Phase 1b trial of Soricimed’s SOR-C13

IntelGenx files provisional U.S. patent for VetaFilm high loading oral film platform

111 Inc. in pact with Jilin Baiyi Doctor Group for internet medical services

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter